Differential prognostic impact of the mutational status of B-RAF and N-RAS in melanoma

被引：0
|
作者：
Ugurel, S
Thirumaran, RK
Blöthner, S
Gast, A
Sucker, A
Müller-Berhaus, J
Rittgen, W
Hemminki, K
Kumar, R
Schadendorf, D
机构：
[1] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany
[2] Univ Med Ctr Mannheim, Dept Dermatol, Skin Canc Unit, Mannheim, Germany
[3] German Canc Res Ctr, Cent Unit Biostat, D-6900 Heidelberg, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2006年 / 15卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：234 / 234
页数：1
相关论文
共 50 条
  • [21] Raf proteins and cancer: B-Raf is identified as a mutational target
    Mercer, KE
    Pritchard, CA
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2003, 1653 (01): : 25 - 40
  • [22] 5-Arylidene(chromenyl-methylene)-thiazolidinediones: Potential New Agents against Mutant Oncoproteins K-Ras, N-Ras and B-Raf in Colorectal Cancer and Melanoma
    Nastasa, Cristina
    Tamaian, Radu
    Oniga, Ovidiu
    Tiperciuc, Brindusa
    MEDICINA-LITHUANIA, 2019, 55 (04):
  • [23] B-RAF is a therapeutic target in melanoma
    Karasarides, M
    Chiloeches, A
    Hayward, R
    Niculescu-Duvaz, D
    Scanlon, I
    Friedlos, F
    Ogilvie, L
    Hedley, D
    Martin, J
    Marshall, CJ
    Springer, CJ
    Marais, R
    ONCOGENE, 2004, 23 (37) : 6292 - 6298
  • [24] B-RAF: A contributor to the melanoma phenotype
    Heath, E. M. L.
    Kaufman, K. L.
    Christopherson, R. I.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2011, 43 (01): : 29 - 32
  • [25] B-RAF is a therapeutic target in melanoma
    Maria Karasarides
    Antonio Chiloeches
    Robert Hayward
    Dan Niculescu-Duvaz
    Ian Scanlon
    Frank Friedlos
    Lesley Ogilvie
    Douglas Hedley
    Jan Martin
    Christopher J Marshall
    Caroline J Springer
    Richard Marais
    Oncogene, 2004, 23 : 6292 - 6298
  • [26] Erratum, The role of B-RAF in melanoma
    Vanessa C. Gray-Schopfer
    Silvy da Rocha Dias
    Richard Marais
    Cancer and Metastasis Reviews, 2005, 24 : 367 - 367
  • [27] B-RAF, naevi and melanoma: a complex relationship
    Kittler, H.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (05) : 931 - 932
  • [28] Value of the histopathological features in predicting B-RAF status in cutaneous malignant melanoma
    Penaranda, J. M. Suarez
    Silva, O. Figueroa
    Gestal, A. Estany
    Bouso, M.
    Aliste, C.
    Aguilar, M. D. Sanchez
    VIRCHOWS ARCHIV, 2016, 469 : S142 - S142
  • [29] Hyperactivation of MEK-ERK1/2 signaling and resistance to apoptosis induced by the oncogenic B-RAF inhibitor, PLX4720, in mutant N-RAS melanoma cells
    Kaplan, F. M.
    Shao, Y.
    Mayberry, M. M.
    Aplin, A. E.
    ONCOGENE, 2011, 30 (03) : 366 - 371
  • [30] Involvement of B-Raf in uveal melanoma development
    Kilic, E
    Brüggenwirth, HT
    Mooy, CM
    Verbiest, M
    de Klein, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U361 - U361
12345